ranibizumab

noun

ran·​i·​biz·​u·​mab ˌra-nə-ˈbi-zü-ˌmab 

: an antiangiogenic drug that is a genetically engineered monoclonal antibody administered by injection into the eye especially to treat age-related macular degeneration and diabetic retinopathy

Note: Ranibizumab acts by binding to and inhibiting the activity of vascular endothelial growth factor. It is marketed under the trademark Lucentis.